Angiotensin II increases intrarenal transforming growth factor-β1 in rats submitted to sodium overload independently of blood pressure

Hypertension Research

Volumn 31, Issue 4, 2008, Pages 707-715

  Rosón, María I ^a   Cao, Gabriel ^c   della Penna, Silvana ^a   Gorzalczany, Susana ^a   Pandolfo, Marcela ^d   Toblli, Jorge E ^b,c   Fernández, Belisario E ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c HOSPITAL ALEMÁN   (Argentina)

^d University of Buenos Aires   (Argentina)

Author keywords

Angiotensin II; Kidney; Sodium; Transforming growth factor 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; HYPERTONIC SOLUTION; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOTONIC SOLUTION; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHEMICAL INTERACTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GLOMERULUS; IMMUNOHISTOCHEMISTRY; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION TEST; KIDNEY TUBULE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RENOVASCULAR HYPERTENSION; SALT LOADING; SPRAGUE DAWLEY RAT;

ACTINS; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; GLOMERULAR FILTRATION RATE; HYPERTENSION, RENAL; KIDNEY; MALE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; VASOCONSTRICTOR AGENTS;

EID: 44649169608     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.707     Document Type: Article

References (16)

1. Sanders PW: Effect of salt intake on progression of chronic kidney disease. Curr Opin Nephrol Hypertens 2006; 15: 54-60.
2. Ruiz-Ortega M, Esteba V, Ruperez M, et al: Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens 2006; 15: 159-166.
3. Kobori H, Ozawa Y, Suzaki Y, Nishiyama A: Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol 2005; 16: 2073-2080.
4. Wolf G: Role of reactive oxygen species in angiotensin II-mediated renal growth, differentiation, and apoptosis. Anti-oxid Redox Signal 2005; 7: 1337-1345.
5. Ruiz-Ortega M, Lorenzo O, Ruperez M, Blanco J, Egido J: Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. Am J Pathol 2001; 158: 1743-1756.
6. Wolf G: Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-β pathway. Kidney Int 2006; 70: 1914-1919.
7. Naito T, Masaki T, Nikolic-Paterson DJ, Tanji C, Yorioka N, Kohno N: Angiotensin II induces thrombospondin-1 production in human mesangial cells via MAPK and JNK: a mechanism for activation of latent TGF-β1. Am J Physiol Renal Physiol 2004; 286: F278-F287.
8. Matavelli LC, Zhou, Varagic J, Susic D, Frolich ED: SALT-loading produces severe renal hemodynamic dysfunction independentof arterial pressure in sponteneously hypertensive rats. Am J Heart Circ Physiol 2006; 292: H814-H819.
9. Brezniceanu ML, Wei CC, Zhang SL, et al: Transforming growth factor-beta 1 stimulates angiotensinogen gene expression in kidney proximal tubular cells. Kidney Int 2006; 69: 1977-1985.
10. Roson MI, Cavallero S, Delia Penna S, et al: Acute sodium overload produces renal tubulointerstitial inflammation in normal rats. Kidney Int 2006; 70: 1439-1446.
11. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) immunoperoxidase techniques: a comparison between ABC an unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580.
12. Abe M, O'Connor P, Kaldunski M, Liang M, Roman RJ, Cowley AW: Effect of sodium delivery on superoxide and nitric oxide in the medullary thick ascending limb. Am J Physiol Renal Physiol 2006; 291: F350-F357.
13. Valles P, Wysocki J, Batlle D: Angiotensin II and renal tubular ion transport. Scientific World Journal 2005; 5: 680-690.
14. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of NF-κB transcription factor and HIV. EMBO J 1991; 10: 2247-2258.
15. Dandona P, Kumar V, Aljada A, et al: Angiotensin II receptor blocker valsartan supresses reactive oxygen species geration in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action. J Clin Endocrinol Metab 2003; 88: 4496-4501.
16. Vallon V, Lang F: New insights into the role of serum and glucocorticoid-ducible kinase SGK1 in the regulation of renal function and blood pressure. Curr Opin Nephrol Hypertens 2005; 14: 59-66.